Comparison of diagnostic and prognostic value of serum procalcitonin and serum lactate in pediatric sepsis


  • Antony Leo Jerry Department of Pediatrics, Sree College Balaji Medical and Hospital, Chennai, Tamil Nadu, India
  • Sundari S. Department of Pediatrics, Sree College Balaji Medical and Hospital, Chennai, Tamil Nadu, India
  • Alph Shirley S. Department of Surgery, Government Headquarters Hospital, Kanyakumari, Tamil Nadu, India
  • Shanthi Ramesh Department of Pediatrics, Sree College Balaji Medical and Hospital, Chennai, Tamil Nadu, India
  • Shiji R. Department of Pediatrics, Sree College Balaji Medical and Hospital, Chennai, Tamil Nadu, India



Septic shock, Serum lactate, Serum procalcitonin, Systemic inflammatory response syndrome (SIRS)


Background: The clinical manifestations of sepsis are highly variable. The signs of both infection and organ dysfunction may be subtle, and thus the most recent international consensus guidelines provide a long list of warning signs of incipient sepsis. Lactic acid, which is a by-product of anaerobic metabolism, can be used as a marker of tissue hypoperfusion. It is being used widely. Procalcitonin has more recently been studied in children.

Methods: Totally 60 Children admitted with Septic Shock in PICU between Ages 3 Months to 12 Years were assessed for Serum Lactate & Serum Procalcitonin levels. Evaluation of the biomarkers was done on individual and combinational basis using receiver operating characteristics curve.

Results: Out of 60 children, male were 40, female were 20 children. In stage-1 serum lactate  level was 47.83 (mg/dl) sensitivity is about 35.63 and specificity was 63.82  off p-value <0.065**.In stage -2 serum procalcitonin was 49.62 (mg/dl) sensitivity is about 37.77 and specificity was 69.28  off p-value <0.549**.In stage -3 serum procalcitonin was 52.89 (mg/dl) sensitivity is about 41.63 and specificity was 73.89  off p-value <0.651**

Conclusions: Early recognition of risk factors will help in timely appropriate therapy and thereby will help in reducing mortality and morbidity in pediatric septic shock. The results suggest that PCT is valid for auxiliary diagnosis of septic conditions in children and used as an indicator of the severity of patients.


Assicot M, Bohuon C, Gendrel D, Raymond J, Carsin H, Guilbaud J. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 2013: 341(8844):515-8.

BalcI C, Sungurtekin H, Gorses E, Sungurtekin U, Kaptanoglu B Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Critical Care 2003 7(1): 85-90.

Becker KL, Snider R, Nylen ES Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010;159(2):253-64.

Carcillo JA, Fields AI; Comitê de Força-Tarefa. Parâmetros de practice clinical Para supported hemodynamic a patient’s paediatrics e neonatais me cheque septic. J Pediatr (Rio J). 2002;78:449-66.

Cargnin S, Jommi C, Canonico PL, Genazzani AA, Terrazzino S. Diagnostic accuracy of HLAB*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analysis review. Pharmacogeno. 2014;15(7):963–976.

Christian L, Marta F, Umberto M, Aintab SD, Silvia B, Eliot C, Anton Ella M. Diagnostic accuracy of preseason (sCD14-ST) and procalcitonin for prediction of bacteremia and bacterial Anaemia in patients with suspected sepsis. J Med Microbial. 2016;65(8):713-9.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(1):858-73.

Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Ann rev Pathol: Mec Dis. 2011;6:19-48.

Jerry AL et al. Int J Contemp Pediatr. 2019 Jan;6(1):122-126

International Journal of Contemporary Pediatrics | January-February 2019 | Vol 6 | Issue 1 Page 126

Ennui-Armada A, Escobar-Cones R, Garcia-De La Torre A, De La Torre-Prados MV. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, preseason and mid-regional pro-adrenomedullin. Clin Chem Lab Med. 2016;54(1):163-8.

Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Müller C. antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9-19.

Gilbert DN. Procalcitonin as a biomarker in respiratory tract infection. Clinical Infectious Diseases. 2011;52(suppl_4):S346-50.

Wu J, Hu L, Zhang G, Wu F, He T. Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis. PLoS One. 2015;10(7):e0133057.

Jat KR, Jhamb U, Gupta VK. Serum lactate levels as the predictor of outcome in pediatric septic shock. Indian J Crit Care Med. 2011;15(2):102-7.

Lapillonne A, Bassoon E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet. 1998;(9110)351:1211-2.

Misner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Actav. 2012;323(1-2):17-29.






Original Research Articles